Health services research

Response to: ‘Should patients starting biologics be screened for COVID-19?’ by Cardenas-de la Garza et al
Robert B M Landewé, Hendrik Schulze-Koops

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218470; DOI: 10.1136/annrheumdis-2020-218470
Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?’ by Marques et al
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218431; DOI: 10.1136/annrheumdis-2020-218431
Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
Emma Dures, Julie Taylor, Sasha Shepperd, Sandeep Mukherjee, Joanna Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1031-1036; DOI: 10.1136/annrheumdis-2020-217301
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD
Maurizio Benucci, Arianna Damiani, Gianfranco Giannasi, Francesca Li Gobbi, Luca Quartuccio, Valentina Grossi, Maria Infantino, Mariangela Manfredi

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218214; DOI: 10.1136/annrheumdis-2020-218214
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
Robert BM Landewé, Pedro M Machado, Féline Kroon, Hans WJ Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D Isaacs, Xavier Mariette, Iain McInnes, Ulf Mueller-Ladner, Peter Openshaw, Josef S Smolen, Tanja A Stamm, Dieter Wiek, Hendrik Schulze-Koops

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 851-858; DOI: 10.1136/annrheumdis-2020-217877
Associations of regular glucosamine use with all-cause and cause-specific mortality: causality assumptions need to be checked
Saeid Safiri, Mohammad Ali Mansournia

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217732; DOI: 10.1136/annrheumdis-2020-217732
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist
Elizabeth R Graef, Jean W Liew, Michael S Putman, Julia F Simard, Emily Sirotich, Francis Berenbaum, Alí Duarte-García, Rebecca Grainger, Carly Harrison, Maximilian F Konig, Peter Korsten, Laurie Proulx, Dawn P Richards, Philip C Robinson, Sebastian E Sattui, Manuel Francisco Ugarte-Gil, Kristen J Young, Alfred HJ Kim, Jeffrey A Sparks

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 734-736; DOI: 10.1136/annrheumdis-2020-217480
Does hydroxychloroquine prevent the transmission of COVID-19?
Flavio L Heldwein, Adriano Calado

Annals of the Rheumatic Diseases Jun 2020, 79 (6) e60; DOI: 10.1136/annrheumdis-2020-217501
Gender gap in rheumatology: speaker representation at annual conferences
Kanika Monga, Jean Liew

Annals of the Rheumatic Diseases May 2020, annrheumdis-2020-217673; DOI: 10.1136/annrheumdis-2020-217673
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann Castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywell, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin

Annals of the Rheumatic Diseases Jan 2020, 79 (1) 31-38; DOI: 10.1136/annrheumdis-2019-215315

Main menu

Health services research

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Health services research

Pages